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A B S T R A C T
Objective: To identify the prevalence of non-adherence to drug therapy for elderly patients 
in primary care in Blumenau, SC, Brazil.
Methods: This is a cross-sectional, population-based epidemiological study. A  randomly 
selected sample of users who attended the pharmacies of 14 units of primary healthcare 
answered the questionnaire’s study variables. The prevalence of non-adherence was 
measured using a self-reported questionnaire. A logistic regression model to calculate odds 
ratio was performed to estimate the association between risk factors and non-adherence.
Results: Of the 151 elderly individuals interviewed, 84.1% reported continuous use of their 
medicines. The average age of the participants was 69.04 years. Regarding the characteristics 
of the medications, an average of 4.3 medicines were used by the elderly, and diseases of 
the circulatory system were the most prominent (43.3%). The prevalence of non-adherence 
was 35.4%. Logistic regression showed an association between non-adherence and “prior 
stopping treatment because of lack of medication” and “inappropriately prescribed 
medication use” (p < 0.005).
Conclusion: The results reinforce the need to improve public policy and management 
processes aimed at ensuring people’s access to essential medicines and qualify the process 
of prescribing health professionals as a way to improve treatment adherence in the elderly.
© 2012 Elsevier Editora Ltda. 
Avaliação da adesão terapêutica em idosos atendidos na atenção 
primária
R E S U M O
Objetivo: Identificar a prevalência de não adesão à terapia medicamentosa dos idosos 
atendidos na atenção primária de Blumenau, SC, Brasil.
Métodos: Estudo epidemiológico observacional, seccional, de base populacional com 
amostra aleatória de usuários que compareceram às farmácias de 14 unidades de atenção 
primária à saúde e responderam o questionário com as variáveis de estudo. A prevalência 
de não adesão foi medida por meio de um questionário autorrelatado. A associação entre 
variáveis de estudo e não adesão foi estimada pelo odds ratio por meio de modelo de 
regressão logística.
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Resultados: Dos 151  idosos entrevistados, 84,1% referiram utilizar medicação contínua. 
A média de idade foi de 69,04 anos. Com relação às características médico-assistenciais, a 
média de medicamentos utilizados foi de 4,3, e patologias do aparelho circulatório apareceu 
como destaque (43,3%) entre as doenças de base. A prevalência de não adesão foi de 35,4%. 
As variáveis “interrupção prévia por falta de medicamento” e “uso de medicamentos com 
prescrição inadequada” se mostraram associadas à não adesão (p < 0,005).
Conclusão: Os resultados reforçam a necessidade de melhorar as políticas públicas e 
os processos gerenciais que visem garantir o acesso da população aos medicamentos 
essenciais, bem como qualificar o processo de prescrição dos profissionais de saúde como 
forma de melhorar a adesão terapêutica em idosos.
Introduction
According to the World Health Organization (WHO), the number 
of older adults will be higher than the number of children 
worldwide by 2025.1 Brazil, with a current life expectancy of 
72.9 years,2 is also following that global trend and thus might 
rank sixth among countries with the largest number of older 
adults by that time.1 Physiological and biochemical changes 
occur together with age,3 which might favour the development 
of diseases, including many chronic diseases,4-6 and thus 
behave as predictors of pharmacological treatment.4,7
Pharmacological agents make a significant contribution to 
healthcare, and thus are a part of most therapeutic approaches. 
However, patients must adhere to the treatments prescribed so 
that outcomes meet expectations. For this reason, adherence 
to pharmacological treatment is one of the indicators of the 
effectiveness of healthcare services and programmes.6-9
WHO defines adherence as “the extent to which a person’s 
behaviour corresponds to agreed recommendations from a 
healthcare provider”,7 thus emphasising the collaboration 
between the target of care and the care provider.4,10-12
The rates of non-adherence to pharmacological treatments 
are estimated to vary from 41 to 74% among individuals older 
than 60 years old. Non-adherence accounts for approximately 
10% of hospital admissions11 and has clinical and economic 
consequences, such as falls and exacerbations of disease.10,11,13
Several factors contribute to successful adherence, including 
the patient and/or caregiver’s socioeconomic level, the 
presence or absence of motor and cognitive deficits, patient’s 
understanding of disease, and a satisfactory doctor-patient 
relationship.10,11,14,15 Understanding the factors that promote 
adherence or non-adherence is crucial to improve the care 
provided to older adults.7
The aim of the present study was to identify the frequency 
of medication use in older adults attending primary care and 
the factors associated with use.
Methods
The present study was a cross-sectional, quantitative, 
observational, epidemiological, population-based study 
conducted with users of primary care services affiliated with 
the Unified Health System (Sistema Único de Saúde – SUS) in 
Blumenau, SC. In this county, primary care is provided through 
two modalities: at General Outpatient Clinics (GOCs), and by 
Family Health Strategy (FHS) teams. The latter comprises a 
doctor, a nurse, nursing technicians, and community health 
agents, whereas the GOCs include general practitioners, 
paediatricians, obstetrician-gynaecologists, nurses, psycho-
logists, and social workers. Both modalities also include oral 
healthcare providers.
To estimate the prevalence of non-adherence, the sample 
size was calculated based on an expected prevalence of 50% 
with 5% of precision, a 95% confidence interval, and a design 
effect of 2, which corresponded to a total of 768 participants. It 
was estimated that 15% of that population was of older adults, 
i.e., 115 individuals who reported being older than 60 years old, 
which is the age range that WHO attributes to older adults in 
developing countries.
The sample was obtained in two stages (units and users) 
and proportionally stratified as a function of the total number 
of users at each FHS and GOC unit. Users who visited the 
pharmacies at 14 centres (three GOC and 11 FHS units) were 
randomly selected, signed an informed consent form and were 
interviewed by previously trained investigators who applied 
a questionnaire that addressed the variables under study. 
Following the stage of data collection, the questionnaires were 
reviewed, and the data were entered twice into an electronic 
database (EpiData version 3.1 – public domain).
Non-adherence to treatment was considered the 
independent variable. The prevalence of non-adherence 
was calculated based on a previously tested and validated 
questionnaire16 comprising four close-ended questions to be 
answered as yes or no: 1) Do you sometimes forget to take 
your medication? 2) Are you sometimes careless in the use of 
your medication? 3) When you feel better, do you sometimes 
stop taking your medication? and 4) If you feel worse when 
you take your medication, do you sometimes stop taking it? 
Whenever any of the four questions answered affirmatively, 
the individual was considered non-adherent to treatment.
The remainder of the variables corresponded to medical 
care issues (type of healthcare centre, primary disease, length 
of treatment, number of drugs, drugs prescribed, reported 
adverse reactions, previous treatment discontinuance, 
© 2012 Elsevier Editora Ltda. 
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information given on the medication, and access to medication) 
and socio-demographic characteristics (age in years, gender, 
self-reported skin colour/ethnicity, marital status, school 
attendance in years, and consumer class).
The volunteers’ economic level was assessed using the 
criteria for economic classification formulated by the Brazilian 
Association of Market Research Companies12 (Associação 
Brasileira de Empresas de Pesquisa - ABEP).
Inappropriate drug prescription was assessed by comparing 
the medications prescribed by doctors and the medications 
included in the Beers-Fick criteria. The criteria are distributed 
across two tables: one lists 48 drugs and/or classes of drugs 
that should be avoided in older adults and the causes for 
concern, independently from diagnoses or conditions, while 
the other lists the medications that should be avoided in older 
adults corresponding to 20 diagnoses or conditions.17
The data were processed and tabulated using the 
software STATA 9.0. The initial tables described the sample’s 
socioeconomic and medical care-related characteristics. 
Then, the prevalence of non-adhesion was calculated. The 
association between proportions was assessed by means of 
the chi-squared or Fisher’s exact test as befitting. In the case 
of continuous variables, the measures of central tendency and 
dispersion were calculated, and the means were compared 
using Student’s t-test.
The association between the outcome variable “non-
adherence” (categorical) and each independent variable 
(univariate analysis) was investigated by calculating odds 
ratios (ORs) with the corresponding 95% confidence interval 
(CI). In multivariate analysis, the ORs were calculated by means 
of unconditional logistic regression. All of the variables that 
exhibited p-values < 0.20 on univariate analysis were included 
in the model. By means of backward stepwise selection, 
variables were gradually removed from the model, and only 
the ones with p-values < 0.05 or that contributed to a better fit 
of the final model remained.
The significance level was established at p < 0.05.
The study complied with the Declaration of Helsinki and 
was approved by the research ethics committee of the Regional 
University of Blumenau Foundation (Fundação Universidade 
Regional de Blumenau - FURB), ruling no. 086/10.
Results
A total of 151 older adults were included in the study, 127 of 
whom (84.1%) reported the presence of chronic diseases and 
consequent continuous use of medication. Table 1 describes 
the distribution of the participants according to certain 
socio-demographic characteristics.
The average age of the sample was 69.04 years old (standard 
deviation, SD= 7.0), with a median of 67.81 years old. The 
average age did not exhibit a statistically significant difference 
as a function of gender.
Most of the participants (71, 47.0%) reported being married 
or having a stable union; most (121, 81.1%) reported being 
white.
The average school attendance was 4.11 years (SD = 3.1), 
with median of 4.0 years.
With respect to their consumer class, level C predominated 
(89, 58.9%), while no volunteer corresponded to class E.
With respect to the medical care-related characteristics 
(Table 2), the average number of drugs per volunteer was 4.29 
(SD = 2.33), with a median of 4.0, and 65 participants (43.0%) 
used more than 5 drugs. The average number of drugs per 
volunteer did not exhibit a statistically significant difference 
as a function of gender, age range, or type of healthcare centre. 
Inappropriate drug prescription was found in 16.5% of the 
sample and exhibited a correlation with the adverse reactions 
reported (p = 0.04).
Most participants (91, 72.2%) stated that they had 
never discontinued treatment previously. Analysis of the 
association between economic class and drug discontinuation 
due to unavailability at the public network showed that 
discontinuation occurred in 68.6% (24) of the volunteers in 
class D versus 25.7% (9) in classes A and B, and 5.7% (2) in class 
C, although the difference was statistically non-significant 
(p = 0.23).
Analysis of the primary diseases found a predominance of 
afflictions of the circulatory system (65, 43.3%), followed by 
endocrine, metabolic, and nutritional disorders (36, 24.0%).
The prevalence of non-adherence among the volunteers 
using continuous medication (n = 127) was 35.4% (95% CI 
27.2-44.4%). The results of univariate analysis of the correlation 
between the investigated variables clustered in groups, and 
the levels of non-adherence according to the Morisky scale are 
described in Table 2.
The only variables that exhibited association with 
non-adherence were “previous discontinuation due to lack 
of medication” and “inappropriate medication prescription”. 
The variables “consumer class”, “how do you feel relative to 
your treatment”, and “adverse reactions reported” exhibited 
p-values < 0.20 and were included in the multivariate analysis.
The final logistic regression model is described in Table 3.
Discussion
The challenge posed by adherence to treatment is greater in 
older adults. That fraction of the population represents up 
to 50%18 of multidrug users due to the higher prevalence of 
chronic degenerative illnesses.13,15,18-20
Among the population of older adults in Blumenau, 
there are more women (58.15%) than men.21 In the present 
study, women represented 72.2% of the primary care users 
older than 60 years old. The reason might be that women 
seek healthcare more often than men,22,23  resulting in 
greater use of medication,3,4,18 and women also frequently 
assume responsibility for the family’s well-being and 
thus go to pharmacies to pick up medications for other 
family members.15 A second relevant socio-demographic 
characteristic of the present sample was the predominance 
of younger elderly (60-69 years old) and married individuals 
as well as of low levels of schooling. This profile agrees with 
previously reported profiles in studies conducted on older 
adults in the primary care setting.18,24
The prevalence of non-adherence to treatment might be 
rated low (35.4%) compared with rates found in other studies, 
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Variable n Frequency (%) 95% CI
Gender
 Male 42 27.8 20.8-35.7
 Female 109 72.2 64.3-79.2
Age range
 60-69 years old 95 62.9 54.7-70.6
 70-79 years old 47 31.1 23.8-39.2
 80 years old and older 9 6.0 2.8-11.0
Marital status
 Married or stable union 71 47.0 38.9-55.3
 Single 9 6.0 2.8-11.0
 Separated 14 9.3 5.2-15.1
 Widowed 57 37.7 30.0-46.0
Skin colour/ethnicity*
 White 121 81.2 74.0-87.1
 Brown 24 16.1 10.6-23.0
 Black 1 0.7 0.0-3.7
 Asian 2 1.3 0.2-4.8
 Other 1 0.7 0.0-3.7
Schooling
 0-2 years 32 21.2 15.0-28.6
 3-4 years 69 45.7 37.6-54.0
 5-8 years 30 19.9 13.8-27.1
 More than 9 years 20 13.2 8.3-19.7
Consumer class
 A-B 21 13.9 8.8-20.5
 C 89 58.9 59.7-66.9
 D 41 27.2 20.2-35.0
Number of drugs
 0-1 13 8.6 4.7-14.3
 2-4 73 48.3 40.1-56.6
 5 or more 65 43.0 35.0-51.3
Prescription of inappropriate medication
 Yes 25 16.6 11.0-23.5
 No 126 83.4 76.5-89.0
Continuous-use medication
 Yes 127 84.1 77.3-89.5
 No 24 15.9 10.5-22.7
Homemade remedies
 Yes 47 31.1 23.8-39.2
 No 104 68.9 60.8-76.2
Treatment discontinuance*
 No 91 72.2 63.5-79.8
 Once 5 4.0 1.3-9.0
 2 or more times 30 23.8 16.7-32.2
Primary disease*
 Neoplasms 6 4.0 1.5-8.5
 Endocrine, nutritional and metabolic diseases 36 24.0 17.4-31.6
 Mental and behavioural disorders 7 4.7 1.9-9.4
 Circulatory system diseases 65 43.3 35.3-51.7
 Respiratory system diseases 7 4.7 1.9-9.4
 Digestive system diseases 10 6.7 3.2-11.9
 Musculoskeletal and connective tissue diseases 10 6.7 3.2-11.9
 Other 9 6.0 2.8-11.1
Length of treatment of primary disease*
 Up to 2 years 32 21.9 15.5-29.5
 2 years or more 114 78.1 70.5-84.5
95% CI, 95% confidence interval.
* Unknown items excluded.
Source: secondary data, 2010.
Table 1 – Socio-demographic characteristics and medical care-related features in older adults attending primary care, 
Blumenau, SC (n = 151).
618 REV ASSOC MED BRAS. 2013;59(6):614-621
which vary from 40 to 75% as a function of the context and the 
methods of assessment used.10,15,25 Such a low prevalence of 
non-adherence might be at least partially explained by the use 
of a questionnaire as the method for data collection because it 
might exhibit a desired answer bias.
Regarding the factors associated with non-adherence, 
only a previous discontinuance due to lack of access to 
medication and having been inappropriately prescribed a 
medication exhibited a statistically significant correlation on 
multivariate analysis. The variable “how do you feel since you 
started treatment” fit into the model but without statistical 
significance. The fact that these variables might be used 
as indicators of service quality and could play a role in the 
occurrence of non-adherence to treatment should be given 
particular attention.
In countries such as Brazil that exhibit wide income 
variation, access to medication exerts significant influence 
on the continuity of treatment.8  In the present study, 
 Non-adherence n (%) OR p
Gender (n = 127)
Male 9 (26.5)
Female 36 (38.7) 1.8 (0.7-4.2) 0.20
Age range (n = 127)
60-69 years old 30 (38.0)
70-79 years old 12 (29.3) 0.7 (0.3-1.5)
80 years old or older 3 (42.9) 1.2 (0.3-5.9) 0.58
Marital status (n = 127)
Married or stable union 21 (36.2)
Single 5 (55.6) 2.2 (0.5-9.1)
Separated or widowed 19 (31.7) 0.8 (0.4-1.8) 0.39
Skin colour/ethnicity (n = 127)
Black, brown and other 8 (33.3)
White 37 (35.9) 1.1 (0.4-2.9) 0.81
Schooling (n = 127)
Secondary and higher education 5 (33.3)
5-8 years 3 (20.0) 0.5 (0.1-2.6)
1-4 years 31 (36.5) 1.1 (0.4-3.7)
Illiterate 6 (50.0) 2.0 (0.4-9.5) 0.42
Consumer class (n = 127)
A-B 4 (22.2)
C 33 (42.3) 2.6 (0.8-8.5)
D 8 (25.8) 1.2 (0.3-4.8) 0.11
Healthcare centre type (n = 127)
General outpatient clinic 20 (30.8)
FHS 25 (40.3) 1.5 (0.7-3.2) 0.26
Number of drugs (n = 127)
1 1 (25.0)
2 or more 44 (35.8) 1.7 (0.2-16.5) 0.66
Prescription of inappropriate medication (n = 127)
No 33 (31.4)
Yes 12 (54.6) 2.6 (1.0-6.7) 0.04
Adverse reactions (n = 127)
No 38 (33.3)
Yes 7 (53.8) 2.3 (0.7-7.4) 0.15
Previous discontinuance due to lack of medication (n = 126)
No 26 (28.6)
1 or more times 19 (54.3) 3.0 (1.3-6.6) 0.008
Previous discontinuance on own account (n = 127)
No 39 (35.8)
1 or more times 6 (33.3) 0.9 (0.3-2.6) 0.84
How do you feel about your treatment (n = 125)
Better 28 (31.5)
The same 12 (42.9) 1.6 (0.7-3.9)
Worse 5 (62.5) 3.6 (0.8-16.3) 0.15
FHS, Family Health Strategy; OR, odds ratio.
Source: secondary data, 2010.
Table 2 – Univariate analysis of the correlation of non-adherence to treatment according to the Morisky scale with social 
and medical care-related factors.
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non-adherence proved to be lower when the drugs were not 
available from the public healthcare network. The availability 
of medications at public facilities is limited, and thus a drug 
needed to treat a definite chronic problem might not be 
available for about one quarter of the year.26 Vasconcelos 
et al. found that a fraction of older adults use lower doses 
of their treatment than the prescribed amount to “store” 
medication in case it becomes unavailable at the public 
healthcare network.27 Teixeira et al. observed that some older 
adults looked for alternatives to purchase the drugs they need 
despite their low income, while other older adults simply 
discontinued them as a function of their high cost.28 Lack of 
access to medication might worsen the individual’s clinical 
condition, resulting in increased expenses for secondary and 
tertiary healthcare.29
No studies were located assessing the association between 
inappropriately prescribed medication and poor adherence. 
The frequency of inappropriately used medication found 
in the present study was lower than the rates reported by 
international studies that applied the same criteria30,31 (16% vs. 
18-21%). These latter two studies, in turn, found associations 
between inappropriately used medication, polypharmacy and 
adverse reactions.30,32
The larger the number of prescribed medications, the 
greater the complexity of the therapeutic regimen,3,33 and 
both factors increase together with age.3 The participants in 
the present study used 4.3 drugs each on average, which is 
slightly higher than the findings of other studies conducted 
in Brazil, which varied from 2.7  to 4.2 drugs per elderly 
patient.3,4,22 The larger the number of drugs, the higher the 
odds for adverse reactions to occur, which is one reason for 
intentional discontinuance.3,34 The symptoms associated with 
adverse reactions and non-adherence predispose older adults 
to being prescribed additional drugs due to the difficulty in 
identifying the actual basic cause of non-responsiveness to 
treatment.35,36 The results of the present study showed that 
higher rates of adherence corresponded to the volunteers who 
did not exhibit adverse reactions.
Therefore, it can be inferred that the association between 
polypharmacy and/or adverse reactions and non-adherence 
belongs in the same causal chain as inappropriate prescriptions. 
Thus, the doctors themselves might involuntarily contribute to 
the occurrence of non-adherence. This hypothesis should be 
more thoroughly investigated by means of longitudinal studies 
and larger samples.
The economic status of older adults might exert 
influen ce on their adherence to treatment because adults 
with low incomes cannot purchase the medication they 
need.15,23,27,37 In addition, low educational levels are a risk 
factor for non-adherence as a function of the complexity of 
the therapeutic regimens18,22,27,33 and as a function of their 
influence on the individual’s understanding of his or her state 
of health, which is a relevant factor with respect to adherence 
to treatment.10,15,22 The results of the present study show that 
socioeconomic variables such as low consumer class and low 
educational level exhibited a correlation with non-adherence, 
albeit in a statistically non-significant manner.
The present study had some limitations. First, the sample 
size was small because the eligible population was restricted 
to individuals within a given age range from a source study, 
resulting in reduced statistical power. The second limitation 
concerned the study setting. The volunteers were recruited at 
pharmacies in primary care centres, which might have caused 
selection bias because the individuals found at that setting 
might have a greater tendency to care for their health and thus 
to exhibit better adherence to treatment. One further limitation 
was related to the method used to measure adherence. The 
Morisky questionnaire is a qualitative instrument that seeks 
to identify non-adherence based on the behaviour of people 
relative to the intake of medication. Thus, the questions are 
not framed with time clauses and do not address clinical 
outcomes. Importantly, other studies in the literature have 
used different methods to assess adherence, thus hindering 
comparison of their results.
Nevertheless, the present study is relevant because it is 
one of the first studies on adherence to treatment in older 
  Non-adjusted OR Adjusted OR p
 95% CI 95% CI  
Previous discontinuance due to lack of medication (n = 126)
 No 1
 1 or more times 3.0 (1.3-6.6) 2.9 (1.3-6.9) 0.01
Prescription of inappropriate medication (n = 127)
 No 1
 Yes 2.6 (1.0-6.7) 2.9 (1.1-7.9) 0.03
How do you feel about your treatment (n = 125)
 Better 1
 The same 1.6 (0.7-3.9) 2.1 (0.8-5.2) 0.13
 Worse  3.6 (0.8-16.3)  3.9 (0.8-18.9) 0.09
95% CI, 95% confidence interval; OR, odds ratio.
Maximum likelihood ratio (LR) test = 15.1, p < 0.005.
Hosmer-Lemeshow goodness-of-fit test = 5.0, p = 0.29.
Table 3 – Final logistic regression model of the correlation of non-adherence to treatment according to the Morisky scale 
with social and medical care-related factors (n = 124).
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adults attending primary care conducted in Brazil. The fact 
that the study included 14 primary care centres (conventional 
outpatient clinics and FHS units) in a mid-sized city is also 
noteworthy because it allows for the application of its results 
to the SUS as a whole.
Conclusion
In the present study, correlations were found between 
non-adherence to treatment and lack of access to medication 
as well as inappropriate medication prescription. The results 
point strongly to the need to improve public policies and 
management processes to ensure population-wide access to 
essential medications and to evaluate the prescriptions made 
by healthcare providers.
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